JIN ZHENG: Open Payments
NPI 1447526793 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,871 in 128 payments from 18 companies in 2025. Trend: 2023 $1,157 · 2024 $1,295 · 2025 $2,871
Food & beverage: $2,871
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 20 | $392 |
| Incyte Corporation | 10 | $306 |
| Janssen Biotech, Inc. | 14 | $268 |
| LEO Pharma Inc. | 7 | $257 |
| Arcutis Biotherapeutics, Inc. | 14 | $255 |
| UCB, Inc. | 11 | $239 |
| Galderma Laboratories, L.P. | 12 | $234 |
| Amgen Inc. | 9 | $219 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $163 |
| Novartis Pharmaceuticals Corporation | 6 | $157 |
Products named: CIBINQO, OPZELURA, TREMFYA, Zoryve, Bimzelx, NEMLUVIO, OTEZLA, ANZUPGO.
Industry payments across NY — which companies pay providers there.
